ConductScience.org, home

Trial · NCT03770338

Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

NCT03770338, Not applicable, Active not recruiting, The University of Hong Kong

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery. Trials, record NCT03770338. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03770338

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery
NCT number
NCT03770338
Status
Active not recruiting
Phases
Not applicable
Enrollment
192 participants, estimated
Lead sponsor
The University of Hong Kong
Conditions
Osteoporosis, Fusion of Spine, Lumbar Region
Interventions
Teriparatide
First posted
2018-12-10
Last updated
2026-05-14

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryInsertional torque Intraoperative insertional torque measurementIntraoperativeMeasurement of the insertional torque of pedicle screws
SecondaryBone Mineral Density (BMD)Preoperative, Immediate postop and 6 month postop dual energy x-ray absorptiometry (DEXA) scanAssessment of BMD before and after treatment
SecondaryComplication rateBaseline, immediate postop, postop 6 weeks, postop 3 months, postop 6 months, postop 12 months, postop 24 monthsscrew loosening, fracture, non-union
SecondaryFusion rateAt 6 months CTFusion rate assessment
SecondaryEQ-5D-5LBaseline, immediate, postop 6 weeks, postop 3 months, postop 6 months, postop 12 months, postop 24 monthsUtility score
SecondaryOswestry Disability Index (ODI)Baseline, immediate postop, postop 6 weeks, postop 3 months, postop 6 months, postop 12 months, postop 24 monthsAssessment of disability
SecondaryShort form 36-item questionnaire (SF-36)Baseline, immediate postop, postop 6 weeks, postop 3 months, postop 6 months, postop 12 months, postop 24 monthsGeneral quality of life score
SecondaryNumeric Rating Scale (NRS)Baseline, immediate postop, postop 6 weeks, postop 3 months, postop 6 months, postop 12 months, postop 24 months
This is a self-perceived severity of back pain. The scores range from minimum 0 (no pain) to maximum 10 (most painful) in a scale of severity. Hence, a higher value represents worse outcome. There are two subquestions: 1) What the patient indicates as the most severe pain in the past 24 hours of answering the questionnaire; 2) The patient indicates the score of the usual pain status in the past 24 hours. 0 represents no pain, 1-3 represents mild pain (nagging, annoying, interfering little with ADLs), 4-6 represents moderate pain (interferes significantly with ADLs), and 7-10 represents severe pain (disabling; unable to perform ADLs).
SecondaryOsteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF)Baseline, immediate postop, postop 6 weeks, postop 3 months, postop 6 months, postop 12 months, postop 24 months
This is a general osteoporosis score with 15 questions split into three categories (mobility, balance and transfer). A Likert scale of 6 answers are possible for each question from "no difficulties" to "unable to perform" in a scale of severity. A total score can be tabulated from adding all domain scores. Higher values indicate better outcome. A 0-100 scale provides a total score, where 0 indicates the worst health status and 100 no difficulties.
SecondaryAmbulatory status assessment (ASA)Baseline, immediate postop, postop 6 weeks, postop 3 months, postop 6 months, postop 12 months, postop 24 monthsFunctional assessment

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03770338

GET https://conductscience.org/api/trials/v1/NCT03770338/registered